We attended the BIO 2010 conference to learn more about the confluence of the pharmaceutical and medical device industries in the growing field of personalized medicine. Based on the crowds at the conference and the encouraging stance of the FDA, there is a movement to bring us instrument geeks into the pharmaceutical business.

The concept of “personalized medicine” is based on the targeting of specific factors that make one individual more receptive to a therapy than another. Pharmaceuticals can alleviate symptoms and cure disease. However, many drugs  only help fewer than half of the people who take them, and many come with the small chance of side-effects – everything from diarrhea or drowsiness  to death. The idea of personalized medicine is that patient populations can be tested to verify before prescription that a drug will be effective for them and that side effects will be minimal.  Tests may be based on a genomic marker or a biological cell structure.

Key Tech has been designing and developing diagnostic devices, both point-of-care and high throughput, for over 10 years now.  In recent years, we’ve been conceiving and developing new drug delivery devices as well and we are witnessing the growing market for patient-friendly medicine delivery and the companion diagnostics that qualify a patient population for targeted drugs.  We’re looking forward to watching this approach to medicine develop and mature.